Lufthansa offers more than 100 holiday destinations this summer

German carrier Lufthansa and budget unit Eurowings aim to offer flights to more than 100 holiday destinations, Chief Executive Carsten Spohr told Bild am Sonntag.

“This is an absolute record in the group’s history,” he was quoted as saying while also demanding that passengers who have received vaccine shots should face fewer restrictions.

“Some countries are opening their borders for vaccinated individuals. We expect more will join,” Spohr said. “We therefore need international, digital proof of vaccinations and tests to finally replace hardly controllable quarantine measures.”

The travel industry has suffered many false starts to a hoped-for recovery, beset by new restrictions, virus variant outbreaks and a sluggish European vaccine rollout.

Lufthansa this week lowered its capacity forecast for flights this year as hopes dwindle for an early summer travel rebound, but the German airline’s cost-cutting drive narrowed quarterly losses. Still, Germany’s flag carrier airline announced Thursday it plans to slash 10,000 more jobs in the country as part of its cost-cutting measures amid the protracted travel slump due to the coronavirus pandemic.

Despite a major downsizing in its workforce already, Lufthansa plans to cut around 10,000 full-time positions in Germany or lower personnel costs to a comparable extent. The group wants to achieve this through voluntary redundancies or part-time work solutions, Lufthansa Chief Financial Officer Remco Steenbergen said while presenting the quarterly figures.

Lufthansa had already cut around 24,000 full-time positions worldwide, which corresponds to around 25,700 employees.

Similar articles

  • Covid-19 vaccine makers slump on expected patent waiver

    Covid-19 vaccine makers slump on expected patent waiver

    The stocks of all companies involved in production of Covid-19 vaccines fell, as US and EU backed the call from the World Health Organisation to waive patent rights claims over the jabs production, Reuters reported. The share slumps came even as some analysts raised doubts about any near-term pressure on Covid-19 vaccine sales from discussions of waiving intellectual property rights, given the manufacturing complexity and scarcity of raw materials. Combined, Pfizer and Moderna have forecast a total of over $45 billion in sales this year for their Covid-19 vaccines.

  • Tesla misses key technology target

    Tesla misses key technology target

    The producer of electric cars Tesla admitted it would miss a target set by its majority owner Elon Musk - to develop full self-driving vehicles by the end of 2021, Reuters reported. The announcement seriously undermines Tesla ambitions to influence the global EV market. Documents released in media earlier this week showed that the company is falling behind announced deadlines while incidents with EVs continue to rise.

  • Bayer loses court fight over EU pesticides

    Bayer loses court fight over EU pesticides

    The German chemical conglomerate Bayer lost an appeal in EU court against a ban related to the usage of pesticides amid growing concerns linked to the extinction on bees, Reuters reported. The European Union's top court upheld the EU's partial ban on insecticides linked to harming bees, preventing their use on certain crops. Bayer appealed to overturn a lower EU court's 2018 decision to uphold the EU ban.